国际生物医学工程杂志
國際生物醫學工程雜誌
국제생물의학공정잡지
INTERNATIONAL JOURNAL OF BIOMEDICAL ENGINEERING
2010年
3期
157-162,后插4
,共7页
朴正福%张海燕%丁淑芹%小林护%佐佐木幸司%菊池爱子%加茂功%樱川宣男%李宁
樸正福%張海燕%丁淑芹%小林護%佐佐木倖司%菊池愛子%加茂功%櫻川宣男%李寧
박정복%장해연%정숙근%소림호%좌좌목행사%국지애자%가무공%앵천선남%리저
羊膜间充质细胞%羊膜干细胞%表面标记%再生医学
羊膜間充質細胞%羊膜榦細胞%錶麵標記%再生醫學
양막간충질세포%양막간세포%표면표기%재생의학
Amnion mesenchymal cells%Amnion stem cells%Surface marker%Regeneration medicine
目的 分离提纯的人羊膜间充质干细胞的生物学特性鉴定.方法 剥去38~40周孕妇剖腹产术后羊膜,用消化酶消化后制备人羊膜间充质细胞(hAMCs)悬浮液.利用流式细胞分选技术从hAMCs中分离提纯干细胞(hAMC-SP细胞),并对干细胞抗原进行鉴定.结果 从hAMCs中分离的hAMC-SP细胞,约占AMCs总数的0.3%.传代培养4~10代后的hAMC-SP细胞表达Nestin、Vimentin、整合素家属成员(CD49b、CD49c、CD49d、CD49e)、CD9、CD13、CD19、CD29、CD44、CD46、CD51、CD59、CD166及干细胞相关的Oct-3/4抗原.HLA-ABC、TRA-1-81及SSEA-4为弱表达;相反CD34、CD45、CD117、CD56、CD90、CD105、CD106、CD133、Flt-1、Musashi 1及HLA-DR无阳性结果,同样TRA-1-60及SSEA-3也表达阴性.体外转化实验表示hAMC-SP细胞在琼脂糖培养基上不形成细胞集落,但阳性对照组的HepG2形成多数细胞集落.结论 hAMC-SP细胞表面标记符合骨髓及脂肪间充质等来源的干细胞特点;hAMC-SP细胞迅速而稳定扩增,无致瘤性.由于来源充足,hAMC-SP细胞在消除HLA-ABC阳性细胞亚群下,同种异体移植在内的广泛的再生医学领域中能成为理想的细胞来源.
目的 分離提純的人羊膜間充質榦細胞的生物學特性鑒定.方法 剝去38~40週孕婦剖腹產術後羊膜,用消化酶消化後製備人羊膜間充質細胞(hAMCs)懸浮液.利用流式細胞分選技術從hAMCs中分離提純榦細胞(hAMC-SP細胞),併對榦細胞抗原進行鑒定.結果 從hAMCs中分離的hAMC-SP細胞,約佔AMCs總數的0.3%.傳代培養4~10代後的hAMC-SP細胞錶達Nestin、Vimentin、整閤素傢屬成員(CD49b、CD49c、CD49d、CD49e)、CD9、CD13、CD19、CD29、CD44、CD46、CD51、CD59、CD166及榦細胞相關的Oct-3/4抗原.HLA-ABC、TRA-1-81及SSEA-4為弱錶達;相反CD34、CD45、CD117、CD56、CD90、CD105、CD106、CD133、Flt-1、Musashi 1及HLA-DR無暘性結果,同樣TRA-1-60及SSEA-3也錶達陰性.體外轉化實驗錶示hAMC-SP細胞在瓊脂糖培養基上不形成細胞集落,但暘性對照組的HepG2形成多數細胞集落.結論 hAMC-SP細胞錶麵標記符閤骨髓及脂肪間充質等來源的榦細胞特點;hAMC-SP細胞迅速而穩定擴增,無緻瘤性.由于來源充足,hAMC-SP細胞在消除HLA-ABC暘性細胞亞群下,同種異體移植在內的廣汎的再生醫學領域中能成為理想的細胞來源.
목적 분리제순적인양막간충질간세포적생물학특성감정.방법 박거38~40주잉부부복산술후양막,용소화매소화후제비인양막간충질세포(hAMCs)현부액.이용류식세포분선기술종hAMCs중분리제순간세포(hAMC-SP세포),병대간세포항원진행감정.결과 종hAMCs중분리적hAMC-SP세포,약점AMCs총수적0.3%.전대배양4~10대후적hAMC-SP세포표체Nestin、Vimentin、정합소가속성원(CD49b、CD49c、CD49d、CD49e)、CD9、CD13、CD19、CD29、CD44、CD46、CD51、CD59、CD166급간세포상관적Oct-3/4항원.HLA-ABC、TRA-1-81급SSEA-4위약표체;상반CD34、CD45、CD117、CD56、CD90、CD105、CD106、CD133、Flt-1、Musashi 1급HLA-DR무양성결과,동양TRA-1-60급SSEA-3야표체음성.체외전화실험표시hAMC-SP세포재경지당배양기상불형성세포집락,단양성대조조적HepG2형성다수세포집락.결론 hAMC-SP세포표면표기부합골수급지방간충질등래원적간세포특점;hAMC-SP세포신속이은정확증,무치류성.유우래원충족,hAMC-SP세포재소제HLA-ABC양성세포아군하,동충이체이식재내적엄범적재생의학영역중능성위이상적세포래원.
Objective We aim to characterize the side population cells obtained by FACS from human amnion cells (hAMC) as stem cells. Methods hAMC were prepared by an enzymatic treatment from the amni-otic membrane separated mechanically from the placenta obtained by Caesarean section of 38-40 weeks after pregnancy. SP cells(hAMC-SP) were isolated by FACS from them and studied for stem cell antigens. Results hAMC-SP cells were about 0.3% among hAMCs. The SP cells at fourth to tenth passages after the culture start were positive for Nestin, Vimentin, integrin family antigens (CD49b、CD49c、CD49d、D49e) and other antigens such as CD9, CD13, CD19, CD29, CD44, CD46, CD51, CD59, CD166, and Oct-3/4. HLA-ABC,TRA-1-81 and SSEA-4 were weakly positive. In contrast, CD34, CD45, CD117, CD56, CD90, CD105, CD106, CD133, Flt-1, Musashi and HLA-DR were negative. Similarly, TRA-1-60 and SSEA-3 were negative. The in vitro transformation assay revealed that hAMC-SP cells did not form colonies in soft agarose cultures, whereas HepG2 cells, used as the positive controls of transformed cells, formed many colonies. Conclusion The cell surface marker studies suggest that hAMC-SP share characteristics with the stem cells obtained from other organs such as bone marrow mesenchymal cells and fat tissues. hAMC-SP cells rapidly and stably proliferate without transforming and they indeed differentiate into several cell types upon exposure to differentiation media. These results suggest that hAMC-SP, after proper depletion of HLA-ABC positive populations, can be used as ideal stem cells in a wide range of regenerative medicine over allogenicity because of their abundant presence.